Summary
Mark Ashworth is a senior project manager and life sciences consultant with nine years’ experience advising biotech, pharma and healthcare clients on licensing, valuations, due diligence, divestments and commercial strategy. With a PhD in biotechnology and hands-on research experience—from industrial placements at GSK and DSM to enzyme engineering in academia—he translates deep scientific insight into pragmatic transaction and launch strategy. He has led deal-oriented advisory work at PharmaVentures and tier-one strategy projects at L.E.K., and recently moved into corporate development and product launch roles at CNX Therapeutics. Comfortable with data science and development workflows, he blends analytic rigour with commercial judgement to de‑risk partnerships and market entries. Based in Oxford, he is particularly skilled at bridging laboratory innovation and investor-ready commercial narratives, often surfacing non-obvious value drivers in complex life-science assets.
9 years of coding experience
5 years of employment as a software developer
Doctor of Philosophy (PhD) Biotechnology, Doctor of Philosophy (PhD) Biotechnology at The University of Manchester
MBiolSci Molecular Biology & Biotechnology, MBiolSci Molecular Biology & Biotechnology at The University of Sheffield